Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
20 Oct 2026AstraZenecaGRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study)Not Yet Recruiting20 Oct 2026AstraZenecaBrazilA Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell LymphomaNot Yet Recruiting20 Oct 2026ChinaNormChinaEffects of a 12-Week Solid Beverage Intervention on Suboptimal Health StatusNot applicableRecruiting20 Oct 2026CSPC Ouyi Pharmaceutical Co., Ltd.ChinaPhase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.Phase 2Not Yet Recruiting20 Oct 2026Curaden AGSwitzerlandIndividualized Management of Plaque-Related Gingival Inflammation in Routine Dental PracticeNot applicableNot Yet Recruiting20 Oct 2026Current HealthRPM Signals in Outpatient CAR T TherapyNot Yet Recruiting20 Oct 2026Dignify TherapeuticsUnited StatesA Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.Phase 1Recruiting20 Oct 2026EktaHTunisiaA PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS.Phase 2Not Yet Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, SingaporeA Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesPhase 1Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, CanadaA Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).Phase 1Not Yet Recruiting20 Oct 2026GC Biopharma CorpSouth KoreaClinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or OlderPhase 2, Phase 3Recruiting20 Oct 2026Hoffmann-La RocheDenmark, United KingdomA Study of RO7821657 in Participants With Solid TumorsPhase 1Recruiting20 Oct 2026IBSA Farmaceutici Italia SrlItalySafety and Efficacy of Iron Prophylaxis With on Iron Homeostasis in Healthy Pregnant WomenNot applicableRecruiting20 Oct 2026Meiji Pharma Spain S.A.SpainPost-Market Clinical Follow-up of Intra-Articular Hyaluronic Acid in Hip OsteoarthritisRecruiting20 Oct 2026Metcela Inc.JapanLong-term Safety Study Following to JRM-001 Treatment in Pediatric Patients With Congenital Heart DiseaseRecruiting20 Oct 2026Mitra BioBelgium, Germany, SpainDevelopment and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestRecruiting20 Oct 2026ModernaTX, Inc.United StatesA Study of Updated mRNA Seasonal Influenza VaccinesPhase 4Recruiting20 Oct 2026Necternal LLCUnited StatesA Clinical Study to Evaluate the Effects of a Supplement on Cognitive FunctionNot applicableActive Not Recruiting20 Oct 2026Nivi, Inc.IndiaComparing AI and Standard Pregnancy ChatbotsNot applicableNot Yet Recruiting20 Oct 2026PepsiCo Global R&DUnited StatesA Descriptive Analysis of the Physiological and Behavioral Profiles of Elite Female AthletesEnrolling By Invitation20 Oct 2026Philips Digital & Computational PathologyUnited StatesThis Study is the Clinical Validation Study for Validation for the Digital Pathology System 'SGi 1.0 + EPW 1.0 + Compatible Clinical Displays'Recruiting20 Oct 2026Promoitalia Group SpaItalyEvaluation of MD60002 Device for Facial Skin AgingNot applicableNot Yet Recruiting20 Oct 2026RAI Services CompanyA Study to Assess Nicotine Uptake From a Menthol Electronic Nicotine Delivery System ProductNot applicableNot Yet Recruiting20 Oct 2026Ribocure Pharmaceuticals ABPoland, SwedenRBD1119 in Coronary Artery Disease (CAD)Phase 2Not Yet Recruiting20 Oct 2026Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaThe First-in-Human Study of GW906 InjectionPhase 1Completed20 Oct 2026Verrica Pharmaceuticals Inc.United StatesSafety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)Phase 2Not Yet Recruiting20 Oct 2026Waterstone Pharmaceutical (Wuhan) Co., LTD.ChinaA Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaPhase 3Recruiting// How AOS uses this